BioCentury | Jan 3, 2020
Emerging Company Profile

Click: personalized digital therapeutics for cognitive, neurobehavioral disorders

Click is developing a pipeline of personalized prescription digital therapeutics that could be used alone or in combination with traditional therapeutics to treat cognitive and neurobehavioral disorders. Launched in 2012, Click Therapeutics Inc. markets a...
BC Week In Review | Jan 11, 2019
Company News

Click, Otsuka partner on digital therapy for depression

Click Therapeutics Inc. (San Francisco, Calif.) partnered with Otsuka America Inc. to develop and commercialize CT-152, a digital therapy to treat major depressive disorder (MDD). Otsuka said it will pay Click up to $10 million...
Items per page:
1 - 2 of 2